TVTX logo

Travere Therapeutics (TVTX) Current assets

annual current assets:

$416.70M-$200.07M(-32.44%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TVTX annual total current assets is $416.70 million, with the most recent change of -$200.07 million (-32.44%) on December 31, 2024.
  • During the last 3 years, TVTX annual current assets has fallen by -$166.13 million (-28.50%).
  • TVTX annual current assets is now -32.44% below its all-time high of $616.77 million, reached on December 31, 2023.

Performance

TVTX Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

quarterly current assets:

$374.17M-$42.53M(-10.21%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX quarterly total current assets is $374.17 million, with the most recent change of -$42.53 million (-10.21%) on March 31, 2025.
  • Over the past year, TVTX quarterly current assets has dropped by -$106.91 million (-22.22%).
  • TVTX quarterly current assets is now -45.47% below its all-time high of $686.23 million, reached on September 30, 2023.

Performance

TVTX quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

TVTX Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-32.4%-22.2%
3 y3 years-28.5%-40.7%
5 y5 years-2.9%-8.0%

TVTX Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-32.4%at low-45.5%+15.2%
5 y5-year-32.4%+1.5%-45.5%+15.2%
alltimeall time-32.4%>+9999.0%-45.5%>+9999.0%

TVTX Current assets History

DateAnnualQuarterly
Mar 2025
-
$374.17M(-10.2%)
Dec 2024
$177.47M(+3.1%)
$416.70M(+28.3%)
Sep 2024
-
$324.74M(-12.0%)
Jun 2024
-
$368.98M(-23.3%)
Mar 2024
-
$481.08M(-22.0%)
Dec 2023
$172.19M(-7.5%)
$616.77M(-10.1%)
Sep 2023
-
$686.23M(+26.6%)
Jun 2023
-
$542.05M(-10.4%)
Mar 2023
-
$604.90M(+24.4%)
Dec 2022
$186.19M(-3.9%)
$486.44M(-9.1%)
Sep 2022
-
$534.84M(-8.9%)
Jun 2022
-
$586.78M(-7.0%)
Mar 2022
-
$631.09M(+8.3%)
Dec 2021
$193.77M(-1.7%)
$582.83M(+0.6%)
Sep 2021
-
$579.08M(+5.3%)
Jun 2021
-
$549.80M(-2.7%)
Mar 2021
-
$565.04M(+37.7%)
Dec 2020
$197.03M(+12.1%)
$410.41M(-17.5%)
Sep 2020
-
$497.68M(-1.6%)
Jun 2020
-
$505.56M(+24.3%)
Mar 2020
-
$406.63M(-5.2%)
Dec 2019
$175.74M(-17.7%)
$429.06M(-2.4%)
Sep 2019
-
$439.72M(-3.8%)
Jun 2019
-
$457.01M(-3.9%)
Mar 2019
-
$475.51M(-4.1%)
Dec 2018
$213.48M(+9.7%)
$495.68M(-1.5%)
Sep 2018
-
$502.99M(+80.3%)
Jun 2018
-
$278.92M(-2.7%)
Mar 2018
-
$286.80M(-12.0%)
DateAnnualQuarterly
Dec 2017
$194.54M(+0.8%)
$325.81M(+0.1%)
Sep 2017
-
$325.34M(+1.8%)
Jun 2017
-
$319.66M(-0.8%)
Mar 2017
-
$322.40M(-3.0%)
Dec 2016
$192.93M(-8.3%)
$332.35M(-3.0%)
Sep 2016
-
$342.59M(+14.1%)
Jun 2016
-
$300.16M(+0.8%)
Mar 2016
-
$297.74M(-1.4%)
Dec 2015
$210.33M(+114.3%)
$301.93M(+0.7%)
Sep 2015
-
$299.95M(+22.6%)
Jun 2015
-
$244.74M(+4.8%)
Mar 2015
-
$233.54M(+525.6%)
Dec 2014
$98.14M(+655.0%)
$37.33M(-17.8%)
Sep 2014
-
$45.44M(-14.9%)
Jun 2014
-
$53.40M(+728.8%)
Mar 2014
-
$6.44M(-14.1%)
Dec 2013
$13.00M(+451.2%)
$7.50M(-55.5%)
Sep 2013
-
$16.85M(+4066.1%)
Jun 2013
-
$404.40K(-84.7%)
Mar 2013
-
$2.64M(>+9900.0%)
Dec 2012
$2.36M(>+9900.0%)
-
Nov 2012
-
$3900.00(0.0%)
Aug 2012
-
$3900.00(0.0%)
May 2012
-
$3900.00(0.0%)
Feb 2012
-
$3900.00(0.0%)
Feb 2012
$0.00(0.0%)
-
Nov 2011
-
$3900.00(0.0%)
Aug 2011
-
$3900.00(-2.5%)
Feb 2011
$0.00
$4000.00

FAQ

  • What is Travere Therapeutics annual total current assets?
  • What is the all time high annual current assets for Travere Therapeutics?
  • What is Travere Therapeutics annual current assets year-on-year change?
  • What is Travere Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Travere Therapeutics?
  • What is Travere Therapeutics quarterly current assets year-on-year change?

What is Travere Therapeutics annual total current assets?

The current annual current assets of TVTX is $416.70M

What is the all time high annual current assets for Travere Therapeutics?

Travere Therapeutics all-time high annual total current assets is $616.77M

What is Travere Therapeutics annual current assets year-on-year change?

Over the past year, TVTX annual total current assets has changed by -$200.07M (-32.44%)

What is Travere Therapeutics quarterly total current assets?

The current quarterly current assets of TVTX is $374.17M

What is the all time high quarterly current assets for Travere Therapeutics?

Travere Therapeutics all-time high quarterly total current assets is $686.23M

What is Travere Therapeutics quarterly current assets year-on-year change?

Over the past year, TVTX quarterly total current assets has changed by -$106.91M (-22.22%)
On this page